John D Yasko Jr
Examiner (ID: 12123)
Most Active Art Unit | 3306 |
Art Unit(s) | 3764, 3734, 2899, 3306, 763, 3763, 3742, 3305 |
Total Applications | 3405 |
Issued Applications | 2977 |
Pending Applications | 169 |
Abandoned Applications | 259 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17356775
[patent_doc_number] => 20220017571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHODS FOR CHROMATOGRAPHIC PROTEIN EXTRACTION AND PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/379605
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17379605
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/379605 | METHODS FOR CHROMATOGRAPHIC PROTEIN EXTRACTION AND PURIFICATION | Jul 18, 2021 | Pending |
Array
(
[id] => 17082071
[patent_doc_number] => 20210277077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => RECOMBINANT TRANSMEMBRANE DOMAIN-DEFICIENT STING AS BIOMIMETIC PROTEIN CARRIER FOR CGAMP ENHANCED CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/181884
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/181884 | RECOMBINANT TRANSMEMBRANE DOMAIN-DEFICIENT STING AS BIOMIMETIC PROTEIN CARRIER FOR CGAMP ENHANCED CANCER IMMUNOTHERAPY | Feb 21, 2021 | Pending |
Array
(
[id] => 17168830
[patent_doc_number] => 20210322500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHOD FOR PRODUCING STABLE ACTINIDIA DELICIOSA POWDER WITH HIGH LEVEL BIOACTIVE ACTINIDIN ENZYME
[patent_app_type] => utility
[patent_app_number] => 17/166515
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166515 | METHOD FOR PRODUCING STABLE ACTINIDIA DELICIOSA POWDER WITH HIGH LEVEL BIOACTIVE ACTINIDIN ENZYME | Feb 2, 2021 | Pending |
Array
(
[id] => 16762415
[patent_doc_number] => 20210107996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => PLAP-CAR-EFFECTOR CELLS
[patent_app_type] => utility
[patent_app_number] => 17/115591
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17115591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/115591 | PLAP-CAR-EFFECTOR CELLS | Dec 7, 2020 | Pending |
Array
(
[id] => 16837933
[patent_doc_number] => 20210145945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => Radioprotection, Radiomitigation and Radiorecovery
[patent_app_type] => utility
[patent_app_number] => 17/086500
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/086500 | Radioprotection, Radiomitigation and Radiorecovery | Nov 1, 2020 | Pending |
Array
(
[id] => 16748484
[patent_doc_number] => 20210100493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => BREATH TEST DEVICE AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/060503
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060503
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/060503 | BREATH TEST DEVICE AND METHOD | Sep 30, 2020 | Pending |
Array
(
[id] => 16750153
[patent_doc_number] => 20210102162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => HARVESTING SYSTEMS AND METHODS FOR REMOVAL OF ALGAE SLURRY IMPURITIES
[patent_app_type] => utility
[patent_app_number] => 17/019422
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019422
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/019422 | HARVESTING SYSTEMS AND METHODS FOR REMOVAL OF ALGAE SLURRY IMPURITIES | Sep 13, 2020 | Abandoned |
Array
(
[id] => 16525535
[patent_doc_number] => 20200399615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => Enhanced adoptive cell therapy
[patent_app_type] => utility
[patent_app_number] => 17/010644
[patent_app_country] => US
[patent_app_date] => 2020-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010644
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/010644 | Enhanced adoptive cell therapy | Sep 1, 2020 | Pending |
Array
(
[id] => 17532376
[patent_doc_number] => 20220110985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND 3'GALACTOSYLLACTOSE
[patent_app_type] => utility
[patent_app_number] => 17/429645
[patent_app_country] => US
[patent_app_date] => 2020-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429645
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/429645 | NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND 3'GALACTOSYLLACTOSE | Jun 3, 2020 | Pending |
Array
(
[id] => 17472458
[patent_doc_number] => 20220079962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND DIETARY BUTYRATE
[patent_app_type] => utility
[patent_app_number] => 17/283287
[patent_app_country] => US
[patent_app_date] => 2020-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283287
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/283287 | NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND DIETARY BUTYRATE | Jun 3, 2020 | Pending |
Array
(
[id] => 17670976
[patent_doc_number] => 20220184143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => COMPOSITIONS AND METHODS OF MODULATING CASOTRANSMITTER SIGNALING
[patent_app_type] => utility
[patent_app_number] => 17/432225
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432225 | COMPOSITIONS AND METHODS OF MODULATING CASOTRANSMITTER SIGNALING | Feb 18, 2020 | Pending |
Array
(
[id] => 17518669
[patent_doc_number] => 20220104517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING INTESTINAL DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/425080
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/425080 | METHODS AND COMPOSITIONS FOR TREATING INTESTINAL DISORDER | Jan 22, 2020 | Pending |
Array
(
[id] => 17472497
[patent_doc_number] => 20220080001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING IMMUNE CHECKPOINT INHIBITOR ASSOCIATED COLITIS
[patent_app_type] => utility
[patent_app_number] => 17/422719
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -76
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422719
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422719 | METHODS AND COMPOSITIONS FOR TREATING IMMUNE CHECKPOINT INHIBITOR ASSOCIATED COLITIS | Jan 15, 2020 | Pending |
Array
(
[id] => 17213098
[patent_doc_number] => 20210346434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => Fermented formula with non-digestible oligosaccharides for use in rotavirus induced infection
[patent_app_type] => utility
[patent_app_number] => 17/283265
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/283265 | Fermented formula with non-digestible oligosaccharides for use in rotavirus induced infection | Jan 15, 2020 | Pending |
Array
(
[id] => 17256808
[patent_doc_number] => 20210369793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => PHASCOLARCTOBACTERIUM FAECIUM FOR USE IN THE PREVENTION AND TREATMENT OF OBESITY AND ITS COMORBIDITIES
[patent_app_type] => utility
[patent_app_number] => 17/298377
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298377
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/298377 | PHASCOLARCTOBACTERIUM FAECIUM FOR USE IN THE PREVENTION AND TREATMENT OF OBESITY AND ITS COMORBIDITIES | Dec 1, 2019 | Pending |
Array
(
[id] => 17336334
[patent_doc_number] => 20220002665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => AKKERMANSIA MUCINIPHILA STRAIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/279247
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279247
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/279247 | AKKERMANSIA MUCINIPHILA STRAIN AND USE THEREOF | Oct 10, 2019 | Pending |
Array
(
[id] => 17052192
[patent_doc_number] => 20210261626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => GENETICALLY ENCODED POLYPEPTIDE FOR AFFINITY CAPTURE AND PURIFICATION OF BIOLOGICS
[patent_app_type] => utility
[patent_app_number] => 17/268314
[patent_app_country] => US
[patent_app_date] => 2019-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17268314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/268314 | GENETICALLY ENCODED POLYPEPTIDE FOR AFFINITY CAPTURE AND PURIFICATION OF BIOLOGICS | Aug 14, 2019 | Pending |
Array
(
[id] => 17124328
[patent_doc_number] => 20210299096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => MICROORGANISM MIXTURES, MOLECULES DERIVED THEREFROM, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/266717
[patent_app_country] => US
[patent_app_date] => 2019-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266717
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266717 | MICROORGANISM MIXTURES, MOLECULES DERIVED THEREFROM, AND METHODS OF USE THEREOF | Aug 7, 2019 | Pending |
Array
(
[id] => 17065890
[patent_doc_number] => 20210268105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => SELF-ASSEMBLING PEPTIDE SCAFFOLD
[patent_app_type] => utility
[patent_app_number] => 17/258297
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17258297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/258297 | SELF-ASSEMBLING PEPTIDE SCAFFOLD | Jul 11, 2019 | Pending |
Array
(
[id] => 17170696
[patent_doc_number] => 20210324366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => SUPPORTED PLANT PLASMA MEMBRANE LIPID BILAYER ON-A-CHIP
[patent_app_type] => utility
[patent_app_number] => 17/258863
[patent_app_country] => US
[patent_app_date] => 2019-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15538
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17258863
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/258863 | SUPPORTED PLANT PLASMA MEMBRANE LIPID BILAYER ON-A-CHIP | Jul 10, 2019 | Pending |